Press Release

Flow Cytometry Market to Record a CAGR of 10.6%

The Global Flow Cytometry Market size is valued at USD 3.8 billion in 2023 and is estimated to grow at a CAGR of around 10.6% during the forecast period. Flow cytometry is vital in toxicology studies, enabling researchers to assess the effects of drug candidates on various cell types, which is important for safety evaluations. It facilitates monitoring drug compounds' effects on cellular responses, such as cell cycle progression and apoptosis, helping in understanding underlying mechanisms of action. Its aptitude to proficiently and accurately analyze a wide range of cell-based assays has led to its extensive use in pharmaceutical research.

Moreover, the vitroMicroFlow Kit along with the MACSQuant Analyzer 10 provided a fast, standardized, and automated flow cytometry workflow, overcoming these limitations and delivering reproducible and reliable high-content information. Technical advancements in flow cytometry have considerably contributed to market growth. Innovations in instrumentation, data analysis, and application diversity have instigated these progressions. The progression in high-resolution, multi-parameter flow cytometers has enabled researchers to measure and analyze a growing range of cellular characteristics, from surface markers to intracellular proteins and genomics.

Furthermore, deploying advanced technologies such as microfluidics, nanotechnology, and spectral flow cytometry has greatly enhanced the sensitivity, speed, and accuracy of flow cytometry, further states the research report “Global Flow Cytometry Market Analysis, 2024.”

Global Flow Cytometry Market Segmentation Analysis

Cell-based Flow Cytometry to Hold Highest Market Share

Based on technology, the market is bifurcated into Cell-Based Flow Cytometry & Bead-Based Flow Cytometry. Of all, Cell-based flow cytometry captured the largest market share in 2023 and is projected to be the most prominent segment in the forecast period as well. The advancements in technology, including multi-parameter flow cytometry for rare cell analysis are assumed to instigate the growth of the segment in the years ahead. Also, this technology is widely utilized in clinical studies of numerous cell types, including tumor cells in peripheral blood, endothelial cells in the bloodstream, tumor stem cells, and hematopoietic progenitor cells.

North America to Lead the Global Market

North America dominated the Flow Cytometry Market in recent years, primarily due to the well-established healthcare and pharmaceutical industries in the US. This robust substructure has considerably driven the demand for flow cytometry solutions for both clinical & research applications. In addition, extensive R&D initiatives for therapeutic development and growing public-private investments in cancer research have further elevated the demand for flow cytometry instruments and products in the region, contributing to substantial market growth across North America.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Becton, Dickinson & Company, Danaher Corporation, Thermofisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Miltenyi Biotec, Enzo Biochem Inc, Sysmex Corporation, Cytek Biosciences, Biomurex, Cytonome/ST, LLC, Sartorius AG, Union Biometrica, Takara Bio Inc, Apogee Flow Systems, and Others, are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the Global Flow Cytometry Market?
3. What key factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various regions?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?